Rob Hershberg

(Dr. Robert Hershberg M.D. Ph.D.)

Currently holds positions in Fate Therapeutics Inc, Adaptive Biotechnologies Corp and NanoString Technologies Inc

Positions
Position Company Period
Director Fate Therapeutics Inc May 1, 2020 -
Independent Director Adaptive Biotechnologies Corp Feb. 1, 2013 -
Independent Director NanoString Technologies Inc March 2, 2015 -
Chief Scientific Officer Celgene Corp Jan. 8, 2016 - April 28, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-02-12 2024-02-08
US Hillevax Inc (HLVX)
S Sale
11,597 -1.2%
14.93
173,161 USD 		11,597 -1.2% 14.93 173,161 USD
2022-06-06 2022-06-03
S Sale
672 -25.1%
22.75
15,288 USD 		672 -25.1% 22.75 15,288 USD
2021-04-19 2021-04-15
PS Planned sale
118 -5.9%
74.20
8,756 USD 		118 -5.9% 74.20 8,756 USD
2021-04-19 2021-04-15
PS Planned sale
19 -0.9%
72.87
1,385 USD 		19 -0.9% 72.87 1,385 USD
2021-04-19 2021-04-15
PS Planned sale
7 -0.3%
71.75
502 USD 		7 -0.3% 71.75 502 USD
2021-03-17 2021-03-15
PS Planned sale
1,214 -39.1%
67.16
81,532 USD 		1,214 -39.1% 67.16 81,532 USD
2021-03-17 2021-03-15
PS Planned sale
282 -8.3%
66.03
18,620 USD 		282 -8.3% 66.03 18,620 USD
2021-03-17 2021-03-15
PS Planned sale
4 -0.1%
63.58
254 USD 		4 -0.1% 63.58 254 USD
2021-03-10 2021-03-08
PS Planned sale
2,000 -57.1%
44.56
89,120 USD 		2,000 -57.1% 44.56 89,120 USD
2021-03-10 2021-03-08
PS Planned sale
2,000 -100.0%
44.56
89,120 USD 		2,000 -100.0% 44.56 89,120 USD
2021-02-18 2021-02-16
PS Planned sale
69 -3.5%
83.93
5,791 USD 		69 -3.5% 83.93 5,791 USD
2021-02-18 2021-02-16
PS Planned sale
163 -7.7%
82.83
13,501 USD 		163 -7.7% 82.83 13,501 USD
2021-02-18 2021-02-16
PS Planned sale
156 -6.8%
81.79
12,759 USD 		156 -6.8% 81.79 12,759 USD
2021-02-18 2021-02-16
PS Planned sale
159 -6.5%
80.55
12,807 USD 		159 -6.5% 80.55 12,807 USD
2021-02-18 2021-02-16
PS Planned sale
323 -11.7%
79.53
25,688 USD 		323 -11.7% 79.53 25,688 USD
2021-02-18 2021-02-16
PS Planned sale
318 -10.3%
78.40
24,931 USD 		318 -10.3% 78.40 24,931 USD
2021-02-17 2021-02-16
PS Planned sale
2,000 -57.1%
65.45
130,900 USD 		2,000 -57.1% 65.45 130,900 USD
2021-01-20 2021-01-15
PS Planned sale
622 -100.0%
67.05
41,705 USD 		622 -100.0% 67.05 41,705 USD
2021-01-20 2021-01-15
PS Planned sale
1,378 -68.9%
66.34
91,417 USD 		1,378 -68.9% 66.34 91,417 USD
2021-01-19 2021-01-15
PS Planned sale
90 -4.5%
74.55
6,710 USD 		90 -4.5% 74.55 6,710 USD
2021-01-19 2021-01-15
PS Planned sale
291 -12.8%
73.66
21,435 USD 		291 -12.8% 73.66 21,435 USD
2021-01-19 2021-01-15
PS Planned sale
410 -15.3%
72.91
29,893 USD 		410 -15.3% 72.91 29,893 USD
2021-01-19 2021-01-15
PS Planned sale
709 -20.9%
71.77
50,885 USD 		709 -20.9% 71.77 50,885 USD
2020-12-16 2020-12-15
PS Planned sale
241 -100.0%
57.01
13,739 USD 		241 -100.0% 57.01 13,739 USD
2020-12-16 2020-12-15
PS Planned sale
1,759 -87.9%
55.78
98,117 USD 		1,759 -87.9% 55.78 98,117 USD
2020-12-16 2020-12-15
PS Planned sale
812 -30.1%
69.88
56,743 USD 		812 -30.1% 69.88 56,743 USD
2020-12-16 2020-12-15
PS Planned sale
688 -20.3%
68.68
47,252 USD 		688 -20.3% 68.68 47,252 USD
2020-11-18 2020-11-16
PS Planned sale
746 -28.3%
47.03
35,084 USD 		746 -28.3% 47.03 35,084 USD
2020-11-18 2020-11-16
PS Planned sale
754 -22.2%
46.31
34,918 USD 		754 -22.2% 46.31 34,918 USD
2020-11-18 2020-11-16
PS Planned sale
223 -100.0%
48.41
10,795 USD 		223 -100.0% 48.41 10,795 USD
2020-11-18 2020-11-16
PS Planned sale
1,777 -88.8%
47.60
84,585 USD 		1,777 -88.8% 47.60 84,585 USD
2020-10-16 2020-10-15
PS Planned sale
2,000 -100.0%
51.51
103,020 USD 		2,000 -100.0% 51.51 103,020 USD
2020-10-16 2020-10-15
PS Planned sale
1,023 -35.1%
39.54
40,449 USD 		1,023 -35.1% 39.54 40,449 USD
2020-10-16 2020-10-15
PS Planned sale
477 -14.1%
38.93
18,570 USD 		477 -14.1% 38.93 18,570 USD
2020-09-17 2020-09-15
PS Planned sale
163 -7.9%
44.20
7,205 USD 		163 -7.9% 44.20 7,205 USD
2020-09-17 2020-09-15
PS Planned sale
1,337 -39.4%
43.55
58,226 USD 		1,337 -39.4% 43.55 58,226 USD
2020-09-16 2020-09-15
PS Planned sale
2,000 -100.0%
42.58
85,160 USD 		2,000 -100.0% 42.58 85,160 USD
2020-08-19 2020-08-17
PS Planned sale
240 -11.3%
39.26
9,422 USD 		240 -11.3% 39.26 9,422 USD
2020-08-19 2020-08-17
PS Planned sale
846 -28.4%
38.44
32,520 USD 		846 -28.4% 38.44 32,520 USD
2020-08-19 2020-08-17
PS Planned sale
414 -12.2%
37.71
15,612 USD 		414 -12.2% 37.71 15,612 USD
2020-08-19 2020-08-17
PS Planned sale
561 -100.0%
40.04
22,462 USD 		561 -100.0% 40.04 22,462 USD
2020-08-19 2020-08-17
PS Planned sale
1,439 -72.0%
39.13
56,308 USD 		1,439 -72.0% 39.13 56,308 USD
2020-07-17 2020-07-15
PS Planned sale
500 -100.0%
44.58
22,290 USD 		500 -100.0% 44.58 22,290 USD
2020-07-17 2020-07-15
PS Planned sale
1,500 -75.0%
43.60
65,400 USD 		1,500 -75.0% 43.60 65,400 USD
2020-07-17 2020-07-15
PS Planned sale
1,155 -37.9%
36.40
42,042 USD 		1,155 -37.9% 36.40 42,042 USD
2020-07-17 2020-07-15
PS Planned sale
345 -10.2%
35.31
12,182 USD 		345 -10.2% 35.31 12,182 USD
2020-06-17 2020-06-15
PS Planned sale
984 -100.0%
43.42
42,725 USD 		984 -100.0% 43.42 42,725 USD
2020-06-17 2020-06-15
PS Planned sale
1,016 -50.8%
42.59
43,271 USD 		1,016 -50.8% 42.59 43,271 USD
2020-06-17 2020-06-15
PS Planned sale
1,500 -44.2%
30.79
46,186 USD 		1,500 -44.2% 30.79 46,186 USD
2020-05-18 2020-05-15
PS Planned sale
3,715 -100.0%
31.20
115,908 USD 		3,715 -100.0% 31.20 115,908 USD
2020-05-18 2020-05-15
PS Planned sale
6,453 -63.5%
30.61
197,526 USD 		6,453 -63.5% 30.61 197,526 USD
2020-05-18 2020-05-15
PS Planned sale
398 -100.0%
36.10
14,368 USD 		398 -100.0% 36.10 14,368 USD
2020-05-18 2020-05-15
PS Planned sale
400 -50.1%
35.23
14,092 USD 		400 -50.1% 35.23 14,092 USD
2020-05-18 2020-05-15
PS Planned sale
1,202 -60.1%
34.14
41,036 USD 		1,202 -60.1% 34.14 41,036 USD
2020-04-27 2020-04-23
PS Planned sale
25,000 -100.0%
29.77
744,250 USD 		25,000 -100.0% 29.77 744,250 USD